MetaCap

Viking Therapeutics (VKTX) News

NASDAQ: VKTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

28.51+0.78 (+2.81%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

VKTX news summary

We found 9 recent headlines mentioning Viking Therapeutics (VKTX): 5 in the past week and 9 in the past 30 days, most often from Nasdaq. For price context, VKTX is up 2.81% at $28.51. The most recent story, "Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock?", was published by Nasdaq on Oct 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Viking Therapeutics headlines

Stocks mentioned alongside VKTX

Compare VKTX